Flutamide-induced hepatotoxicity with possible potentiation by simvastatin

Journal of Association of Physicians of India

Volumn 51, Issue JAN, 2003, Pages 75-77

  Ashar, Unnati ^a   Desai, D ^a   Bhaduri, Anita ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTAMIDE; SIMVASTATIN;

AGED; ARTICLE; CASE REPORT; DRUG POTENTIATION; HUMAN; MALE; PATHOLOGY; PROSTATE TUMOR; TOXIC HEPATITIS;

AGED; DRUG SYNERGISM; FLUTAMIDE; HEPATITIS, TOXIC; HUMANS; MALE; PROSTATIC NEOPLASMS; SIMVASTATIN;

EID: 0037842215     PISSN: 00045772     EISSN: 00045772     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Wysowski DK, Fourcroy JL. Flutamide hepatotoxicity. J Urol 1996;155:209-12.
2. Wysowski DK, Freiman JP, Tourtlet JB, Horton ML 3rd. Fatal and non-fatal hepatotoxicity associated with flutamide. Ann Intern Med 1993;118:860-4.
3. Gomez J, Dupont A, Cusan L, et al. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am J Med 1992;92:465-70.
4. Ballare M, Campanini N, Airoldi G, et al. Hepatotoxicity of hydroxy-methyl-glutaryl-coenzyme. A reductase inhibitors. Minerva Gastroenterol Dietol 1992;38:41-4.
5. Cicognani C, Malavolti M, Morselli-Labate AM, Sama C, Barbara L. Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis. Dig Dis Sci 1996;41:2219-21.